BHI Cough Tablet

Manufacturer: MediNatura Inc
Effective date: 2022-07-11
Label type: HUMAN OTC DRUG LABEL
Version: 5
Source: legacy-cache
Hydrated at: 2026-08-01 21:57:10

Label at a glance#

ProductBHI Cough

Active ingredientANTIMONY POTASSIUM TARTRATE, ATROPA BELLADONNA, BLATTA ORIENTALIS, BRYONIA ALBA WHOLE, ANEMONE HEPATICA VAR. OBTUSA, STAR ANISE, IPECAC, LOBELIA INFLATA, NAPHTHALENE, SODIUM SULFIDE NONAHYDRATE, STACHYS OFFICINALIS, ASPIDOSPERMA QUEBRACHO-BLANCO BARK

Label structure8 sections

Indications and uses

For the temporary relief of minor cough due to colds, throat irritation, and allergies.

Dosage and administration

At first sign of symptoms: Adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Standard dosage: Adults and children 4 years and older: Take 1-2 tablets every 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 4, consult your health professional. Allow tablets to dissolve completely in the mouth, do not swallow .

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Each tablet contains: Antimonium tartaricum 6X, *Belladonna 6X, *Blatta orientalis 8X, *Bryonia alba 8X, *Hepatica triloba 5X, *Illicium anisatum 4X, *Ipecacuanha 4X, *Lobelia inflata 5X, Naphthalinum 6X, Natrum sulphuricum 6X, *Quebracho 6X, *Stachys betonica 4X 25 mg each.

*Natural Ingredients

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Inactive Ingredients: **Dextrose, ** Lactose, Magnesium Stearate, **Maltodextrin
**contains one or more of these ingredients.

PURPOSE

OTC - PURPOSE SECTION

Cough Relief Tablets

Relieves Cough due to:

• Colds

• Throat Irritation

• Allergies

USES

INDICATIONS & USAGE SECTION

For the temporary relief of minor cough due to colds, throat irritation, and allergies.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

At first sign of symptoms: Adults and children 4years and older:

1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage.

Standard dosage: Adults and children 4 years and older:

Take 1-2 tablets every 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 4, consult your health professional.

Allow tablets to dissolve completely in the mouth, do not swallow

WARNINGS

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. Ask a doctor if you have a cough that occurs with too much phlegm (mucus) or a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema. Stop and ask a doctor if cough lasts for more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition. Do not use if known sensitivity to Cough or any of its ingredients exists.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BHI Cough Tablet.jpg

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
62795-1022-2	EA - Each	62795-1022	0bf803e5-129c-45ac-9e43-8a933c131988	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ANEMONE AMERICANA	ACTIVE INGREDIENT	6ICN6T7FEM	1
ANTIMONY POTASSIUM TARTRATE	ACTIVE INGREDIENT	DL6OZ476V3	1
ASPIDOSPERMA QUEBRACHO-BLANCO BARK	ACTIVE INGREDIENT	52B1340190	1
ATROPA BELLADONNA	ACTIVE INGREDIENT	WQZ3G9PF0H	1
BLATTA ORIENTALIS	ACTIVE INGREDIENT	535787266D	1
BRYONIA ALBA WHOLE	ACTIVE INGREDIENT	56K0VVT47P	1
IPECAC	ACTIVE INGREDIENT	62I3C8233L	1
LOBELIA INFLATA	ACTIVE INGREDIENT	9PP1T3TC5U	1
NAPHTHALENE	ACTIVE INGREDIENT	2166IN72UN	1
SODIUM SULFIDE NONAHYDRATE	ACTIVE INGREDIENT	C02T02993U	1
STACHYS OFFICINALIS	ACTIVE INGREDIENT	UO9989Y17N	1
STAR ANISE	ACTIVE INGREDIENT	XKC1657P78	1
ANEMONE AMERICANA	ACTIVE MOIETY	6ICN6T7FEM	1
ANTIMONY CATION (3+)	ACTIVE MOIETY	069647RPT5	1
ASPIDOSPERMA QUEBRACHO-BLANCO BARK	ACTIVE MOIETY	52B1340190	1
ATROPA BELLADONNA	ACTIVE MOIETY	WQZ3G9PF0H	1
BLATTA ORIENTALIS	ACTIVE MOIETY	535787266D	1
BRYONIA ALBA WHOLE	ACTIVE MOIETY	56K0VVT47P	1
IPECAC	ACTIVE MOIETY	62I3C8233L	1
LOBELIA INFLATA	ACTIVE MOIETY	9PP1T3TC5U	1
NAPHTHALENE	ACTIVE MOIETY	2166IN72UN	1
SODIUM CATION	ACTIVE MOIETY	LYR4M0NH37	1
STACHYS OFFICINALIS	ACTIVE MOIETY	UO9989Y17N	1
STAR ANISE	ACTIVE MOIETY	XKC1657P78	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

BHI Cough
ANTIMONY POTASSIUM TARTRATE, ATROPA BELLADONNA, BLATTA ORIENTALIS, BRYONIA ALBA WHOLE, ANEMONE AMERICANA, STAR ANISE, IPECAC, LOBELIA INFLATA, NAPHTHALENE, SODIUM SULFIDE NONAHYDRATE, ASPIDOSPERMA QUEBRACHO-BLANCO BARK, and STACHYS OFFICINALIS
ANTIMONY POTASSIUM TARTRATE
ANTIMONY CATION (3+)
ATROPA BELLADONNA
BLATTA ORIENTALIS
BRYONIA ALBA WHOLE
ANEMONE HEPATICA VAR. OBTUSA
STAR ANISE
IPECAC
LOBELIA INFLATA
NAPHTHALENE
SODIUM SULFIDE NONAHYDRATE
SODIUM CATION
STACHYS OFFICINALIS
ASPIDOSPERMA QUEBRACHO-BLANCO BARK
LACTOSE
MAGNESIUM STEARATE
MALTODEXTRIN
DEXTROSE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
62795-1022	62795-1022-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ANTIMONY POTASSIUM TARTRATE	DL6OZ476V3	ACTIB
ATROPA BELLADONNA	WQZ3G9PF0H	ACTIB
BLATTA ORIENTALIS	535787266D	ACTIB
BRYONIA ALBA WHOLE	56K0VVT47P	ACTIB
ANEMONE HEPATICA VAR. OBTUSA	6ICN6T7FEM	ACTIB
STAR ANISE	XKC1657P78	ACTIB
IPECAC	62I3C8233L	ACTIB
LOBELIA INFLATA	9PP1T3TC5U	ACTIB
NAPHTHALENE	2166IN72UN	ACTIB
SODIUM SULFIDE NONAHYDRATE	C02T02993U	ACTIB
STACHYS OFFICINALIS	UO9989Y17N	ACTIB
ASPIDOSPERMA QUEBRACHO-BLANCO BARK	52B1340190	ACTIB
LACTOSE	J2B2A4N98G	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MALTODEXTRIN	7CVR7L4A2D	IACT
DEXTROSE	IY9XDZ35W2	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 75 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / TOPICAL		104 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / RESPIRATORY (INHALATION)	0.13 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE / ORAL	256.4 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TROCHE / ORAL		315 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / BUCCAL	296.7 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	PELLET / ORAL		24 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, EXTENDED RELEASE / ORAL		173 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	SUSPENSION, EXTENDED RELEASE / ORAL		71 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL		980 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	DROPS / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / BUCCAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		53 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	GRANULE, FOR SUSPENSION / ORAL		14 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	RING / VAGINAL		2 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED / ORAL		96 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	LOZENGE / TRANSMUCOSAL		100 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, DELAYED RELEASE / ORAL		1060 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAMUSCULAR	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, COATED / ORAL		184 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	IMPLANT / SUBCUTANEOUS	0.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, DELAYED RELEASE / ORAL		144 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FOR SUSPENSION / ORAL		131 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	WAFER / ORAL	66 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	IMPLANT / INTRAVITREAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, EXTENDED RELEASE / ORAL		117 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	LOZENGE / ORAL		420 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	193.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	SYSTEM / INTRAVITREAL	0.02 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER, FOR SUSPENSION / ORAL		120 mg	Exact identifier — unii candidate 39 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
6209f6c9-1970-4141-b24a-7bde03a00a86			c3d6c437-bf63-4100-b0f8-d20ecbecc39a	2022-07-11	Warnings	Exact identifier spl id: 6209f6c9-1970-4141-b24a-7bde03a00a86 spl set id: c3d6c437-bf63-4100-b0f8-d20ecbecc39a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.